Results 241 to 250 of about 7,548 (263)

Insulin aspart/insulin degludec

Reactions Weekly, 2017
openaire   +1 more source

Insulin degludec: a new ultra-longacting insulin

The Lancet, 2012
Abd A, Tahrani, Clifford J, Bailey, Anthony H, Barnett   +2 more
openaire   +2 more sources

Insulin signalling and the regulation of glucose and lipid metabolism

Nature, 2001
Alan R Saltiel, C Ronald Kahn
exaly  

Changes in inflammation and insulin pathways mediate the association between resistance training and breast cancer survival

Ca-A Cancer Journal for Clinicians, 2018
exaly  

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

Nature Medicine, 2001
Hironori Waki, Philippe Froguel
exaly  

Novel Agents on the Horizon for Cancer Therapy

Ca-A Cancer Journal for Clinicians, 2009
exaly  

Insulin-like growth factors and neoplasia

Nature Reviews Cancer, 2004
Michael N Pollak, Eva S Schernhammer
exaly  

Insulin-degludec/insulin-aspart

Reactions Weekly
openaire   +1 more source

The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes

Nature, 2014
Rachel J Perry, Varman T Samuel, Kitt F Petersen   +2 more
exaly  

Cefepime/empagliflozin/insulin-degludec/insulin-lispro

Reactions Weekly, 2023
openaire   +1 more source